Weekly highlight of top insider buys: Medtronic Inc. (MDT, Financial), Van Kampen Senior Income Trust (VVR, Financial), Incyte Corp. (INCY, Financial), Worthington Industries Inc. (WOR, Financial), and Investors Real Estate Trust (IRET, Financial)
Medtronic Inc. (MDT): Director James T Lenehan Bought 3,000 Shares
Director of Medtronic Inc., James T Lenehan, bought 3,000 shares on 7/06/10 at an average price of $37.23.
Medtronic is the world's medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Medtronic Inc. has a market cap of $41.01 billion; its shares were traded at around $37.23 with a P/E ratio of 11.6 and P/S ratio of 2.6. The dividend yield of Medtronic Inc. stocks is 2.2%. Medtronic Inc. had an annual average earning growth of 11.5% over the past 10 years. GuruFocus rated Medtronic Inc. the business predictability rank of 4.5-star.
On May 25, Medtronic, Inc. announced financial results for its fourth quarter and fiscal year ended April 30, 2010. Medtronic recorded fiscal year 2010 revenue of $15.817 billion, an 8 percent increase over fiscal year 2009 revenue on both an as reported and constant currency basis. As reported, fiscal year 2010 net earnings were $3.099 billion, or $2.79 per diluted share, an increase of 50 percent and 52 percent, respectively. Non-GAAP net earnings and diluted earnings per share for fiscal year 2010 were $3.577 billion and $3.22, an increase of 9 percent and 10 percent, respectively.
Medtronic Inc. is in the portfolios of nine Gurus: Arnold Van Den Berg, James Barrow, Richard Snow, George Soros, Dodge & Cox, Edward Owens, PRIMECAP Management, Bill Nygren, and Kenneth Fisher.
Last week, Buy: Director James T Lenehan bought 3,000 shares of MDT stock. Buy: Director Jack W Schuler bought 30,000 shares last month. Sell: SVP & Pres Spinal & Biologics Stephen Laneve sold shares in April and March.
Van Kampen Senior Income Trust (VVR): Director R Craig Kennedy Bought 4,500 Shares
Director of Van Kampen Senior Income Trust, R Craig Kennedy, bought 4,500 shares during the past week at an average price of $4.49. Van Kampen Senior Income Trust has a market cap of $1.69 billion; its shares were traded at around $4.49 . The dividend yield of Van Kampen Senior Income Trust stocks is 4.8%.
Van Kampen Senior Income Trust is in the portfolio of Kenneth Fisher.
Last week, Buy: Director R Craig Kennedy bought 2,500 shares of VVR stock.
Incyte Corp. (INCY): CFO David C Hastings Bought 2,000 Shares
CFO of Incyte Corp., David C Hastings, bought 2,000 shares on 7/01/10 at an average price of $12.03.
Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. Incyte Corp. has a market cap of $1.46 billion; its shares were traded at around $12.03 with and P/S ratio of 157.3. Incyte Corp. had an annual average earning growth of 0.4% over the past 10 years.
On May 06, Incyte Corporation reported first quarter 2010 financial results and provided an update on recent clinical accomplishments, including positive top-line results from an ongoing six-month, dose-ranging Phase II trial to evaluate INCB28050 in rheumatoid arthritis (RA) patients.
Last week, Buy: CEO Paul A Friedman and Buy: CFO David C Hastings shares of INCY stock. Sell: EVP, Human Resources Paula J Swain sold 97,917 last month, and Sell: EVP, Chief Drug Dev&Medical Of Richard S Levy sold 20,000 shares in March.
Worthington Industries Inc. (WOR): VP Corp Dev & Treasurer Matthew A Lockard Bought 4,000 Shares
VP Corp Dev & Treasurer of Worthington Industries Inc., Matthew A Lockard, bought 4,000 shares on 7/02/10 at an average price of $13.79.
Worthington Industries is one of the diversified metal processing companies. Worthington Industries Inc. has a market cap of $1.09 billion; its shares were traded at around $13.79 with a P/E ratio of 15.5 and P/S ratio of 0.5. The dividend yield of Worthington Industries Inc. stocks is 2.9%.
On June 29, Worthington Industries, Inc. reported net sales of $626.4 million, and net earnings of $33.1 million, or $0.42 per share, for the fiscal 2010 fourth quarter ended May 31, 2010. For the fiscal year ended May 31, 2010, the Company posted net earnings of $45.2 million, or $0.57 per share, driven by the strong fourth quarter. Sales were down 26% from the prior year to $1,943.0 million.
Worthington Industries Inc. is in the portfolios of George Soros and Mason Hawkins.
Last week, Buy: Director Carl A Jr Nelson, Buy: President, Dietrich Industries John E Roberts, and Buy: VP Corp Dev & Treasurer Matthew A Lockard bought shares of WOR stock. In April, Buy: VP Corp Dev & Treasurer Matthew A Lockard and Buy: President, Dietrich Industries John E Roberts bought shares.
Investors Real Estate Trust (IRET): Director Charles W Morgan Bought 1,131 Shares
Director of Investors Real Estate Trust, Charles W Morgan, bought 1,131 shares on 7/06/10 at an average price of $8.57.
Investors Real Estate Trust is a real estate investment trust operating in the Midwest. Investors Real Estate Trust has a market cap of $642.9 million; its shares were traded at around $8.57 with and P/S ratio of 2.7. The dividend yield of Investors Real Estate Trust stocks is 8%. Investors Real Estate Trust had an annual average earning growth of 2.2% over the past 10 years.
Last week, Buy: Director W David Scott, Buy: Director Charles W Morgan, Buy: SVP - Commercial Asset Mgmt Charles A Greenberg, and Buy: Director Stephen Stenehjem bought shares of IRET stock.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
Medtronic Inc. (MDT): Director James T Lenehan Bought 3,000 Shares
Director of Medtronic Inc., James T Lenehan, bought 3,000 shares on 7/06/10 at an average price of $37.23.
Medtronic is the world's medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Medtronic Inc. has a market cap of $41.01 billion; its shares were traded at around $37.23 with a P/E ratio of 11.6 and P/S ratio of 2.6. The dividend yield of Medtronic Inc. stocks is 2.2%. Medtronic Inc. had an annual average earning growth of 11.5% over the past 10 years. GuruFocus rated Medtronic Inc. the business predictability rank of 4.5-star.
On May 25, Medtronic, Inc. announced financial results for its fourth quarter and fiscal year ended April 30, 2010. Medtronic recorded fiscal year 2010 revenue of $15.817 billion, an 8 percent increase over fiscal year 2009 revenue on both an as reported and constant currency basis. As reported, fiscal year 2010 net earnings were $3.099 billion, or $2.79 per diluted share, an increase of 50 percent and 52 percent, respectively. Non-GAAP net earnings and diluted earnings per share for fiscal year 2010 were $3.577 billion and $3.22, an increase of 9 percent and 10 percent, respectively.
Medtronic Inc. is in the portfolios of nine Gurus: Arnold Van Den Berg, James Barrow, Richard Snow, George Soros, Dodge & Cox, Edward Owens, PRIMECAP Management, Bill Nygren, and Kenneth Fisher.
Last week, Buy: Director James T Lenehan bought 3,000 shares of MDT stock. Buy: Director Jack W Schuler bought 30,000 shares last month. Sell: SVP & Pres Spinal & Biologics Stephen Laneve sold shares in April and March.
Van Kampen Senior Income Trust (VVR): Director R Craig Kennedy Bought 4,500 Shares
Director of Van Kampen Senior Income Trust, R Craig Kennedy, bought 4,500 shares during the past week at an average price of $4.49. Van Kampen Senior Income Trust has a market cap of $1.69 billion; its shares were traded at around $4.49 . The dividend yield of Van Kampen Senior Income Trust stocks is 4.8%.
Van Kampen Senior Income Trust is in the portfolio of Kenneth Fisher.
Last week, Buy: Director R Craig Kennedy bought 2,500 shares of VVR stock.
Incyte Corp. (INCY): CFO David C Hastings Bought 2,000 Shares
CFO of Incyte Corp., David C Hastings, bought 2,000 shares on 7/01/10 at an average price of $12.03.
Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. Incyte Corp. has a market cap of $1.46 billion; its shares were traded at around $12.03 with and P/S ratio of 157.3. Incyte Corp. had an annual average earning growth of 0.4% over the past 10 years.
On May 06, Incyte Corporation reported first quarter 2010 financial results and provided an update on recent clinical accomplishments, including positive top-line results from an ongoing six-month, dose-ranging Phase II trial to evaluate INCB28050 in rheumatoid arthritis (RA) patients.
Last week, Buy: CEO Paul A Friedman and Buy: CFO David C Hastings shares of INCY stock. Sell: EVP, Human Resources Paula J Swain sold 97,917 last month, and Sell: EVP, Chief Drug Dev&Medical Of Richard S Levy sold 20,000 shares in March.
Worthington Industries Inc. (WOR): VP Corp Dev & Treasurer Matthew A Lockard Bought 4,000 Shares
VP Corp Dev & Treasurer of Worthington Industries Inc., Matthew A Lockard, bought 4,000 shares on 7/02/10 at an average price of $13.79.
Worthington Industries is one of the diversified metal processing companies. Worthington Industries Inc. has a market cap of $1.09 billion; its shares were traded at around $13.79 with a P/E ratio of 15.5 and P/S ratio of 0.5. The dividend yield of Worthington Industries Inc. stocks is 2.9%.
On June 29, Worthington Industries, Inc. reported net sales of $626.4 million, and net earnings of $33.1 million, or $0.42 per share, for the fiscal 2010 fourth quarter ended May 31, 2010. For the fiscal year ended May 31, 2010, the Company posted net earnings of $45.2 million, or $0.57 per share, driven by the strong fourth quarter. Sales were down 26% from the prior year to $1,943.0 million.
Worthington Industries Inc. is in the portfolios of George Soros and Mason Hawkins.
Last week, Buy: Director Carl A Jr Nelson, Buy: President, Dietrich Industries John E Roberts, and Buy: VP Corp Dev & Treasurer Matthew A Lockard bought shares of WOR stock. In April, Buy: VP Corp Dev & Treasurer Matthew A Lockard and Buy: President, Dietrich Industries John E Roberts bought shares.
Investors Real Estate Trust (IRET): Director Charles W Morgan Bought 1,131 Shares
Director of Investors Real Estate Trust, Charles W Morgan, bought 1,131 shares on 7/06/10 at an average price of $8.57.
Investors Real Estate Trust is a real estate investment trust operating in the Midwest. Investors Real Estate Trust has a market cap of $642.9 million; its shares were traded at around $8.57 with and P/S ratio of 2.7. The dividend yield of Investors Real Estate Trust stocks is 8%. Investors Real Estate Trust had an annual average earning growth of 2.2% over the past 10 years.
Last week, Buy: Director W David Scott, Buy: Director Charles W Morgan, Buy: SVP - Commercial Asset Mgmt Charles A Greenberg, and Buy: Director Stephen Stenehjem bought shares of IRET stock.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
